0 XP   0   0   0

Torrent Pharmaceuticals Limited
Buy, Hold or Sell?

Should you buy, hold or sell Torrent Pharmaceuticals Limited?

I guess you are interested in Torrent Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Torrent Pharmaceuticals Limited

Let's start. I'm going to help you getting a better view of Torrent Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Torrent Pharmaceuticals Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Torrent Pharmaceuticals Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Torrent Pharmaceuticals Limited. The closing price on 2023-01-25 was INR1,558 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Torrent Pharmaceuticals Limited Daily Candlestick Chart
Torrent Pharmaceuticals Limited Daily Candlestick Chart
Summary









1. Valuation of Torrent Pharmaceuticals Limited




Current price per share

INR1,557.50

2. Growth of Torrent Pharmaceuticals Limited




Is Torrent Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$732.2m$717.9m$14.2m1.9%

How much money is Torrent Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$95.5m$153.9m-$58.3m-61.1%
Net Profit Margin9.1%15.6%--

How much money comes from the company's main activities?

3. Financial Health of Torrent Pharmaceuticals Limited




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings (Pharmaceuticals)  


Richest
#8 / 54

Most Profit
#11 / 54


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Torrent Pharmaceuticals Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Torrent Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 9.1% means that ₹0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 9.1%. The company is making a profit. +1
  • The TTM is 9.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.1%0.0%
TTM9.1%YOY15.6%-6.5%
TTM9.1%5Y11.0%-1.8%
5Y11.0%10Y13.8%-2.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1%3.3%+5.8%
TTM9.1%6.9%+2.2%
YOY15.6%9.9%+5.7%
5Y11.0%6.3%+4.7%
10Y13.8%6.7%+7.1%
1.1.2. Return on Assets

Shows how efficient Torrent Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • 5.9% Return on Assets means that Torrent Pharmaceuticals Limited generated ₹0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 5.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.9%0.0%
TTM5.9%YOY8.9%-3.0%
TTM5.9%5Y6.0%-0.1%
5Y6.0%10Y8.4%-2.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%0.8%+5.1%
TTM5.9%1.3%+4.6%
YOY8.9%1.5%+7.4%
5Y6.0%1.4%+4.6%
10Y8.4%1.4%+7.0%
1.1.3. Return on Equity

Shows how efficient Torrent Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • 13.1% Return on Equity means Torrent Pharmaceuticals Limited generated ₹0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 13.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.1%TTM13.1%0.0%
TTM13.1%YOY21.4%-8.4%
TTM13.1%5Y15.9%-2.9%
5Y15.9%10Y21.5%-5.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ13.1%1.5%+11.6%
TTM13.1%2.0%+11.1%
YOY21.4%3.0%+18.4%
5Y15.9%2.1%+13.8%
10Y21.5%2.0%+19.5%

1.2. Operating Efficiency of Torrent Pharmaceuticals Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Torrent Pharmaceuticals Limited is operating .

  • Measures how much profit Torrent Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y15.7%-15.7%
5Y15.7%10Y15.1%+0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y15.7%5.1%+10.6%
10Y15.1%5.2%+9.9%
1.2.2. Operating Ratio

Measures how efficient Torrent Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are ₹1.08 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 1.080. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.080. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.080TTM1.0800.000
TTM1.080YOY1.036+0.044
TTM1.0805Y1.082-0.002
5Y1.08210Y0.969+0.113
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0801.342-0.262
TTM1.0801.276-0.196
YOY1.0361.169-0.133
5Y1.0821.149-0.067
10Y0.9691.178-0.209

1.3. Liquidity of Torrent Pharmaceuticals Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Torrent Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.20 means the company has ₹1.20 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 1.199. The company is just able to pay all its short-term debts.
  • The TTM is 1.199. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.199TTM1.1990.000
TTM1.199YOY1.129+0.070
TTM1.1995Y1.046+0.154
5Y1.04610Y1.205-0.160
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1992.205-1.006
TTM1.1992.010-0.811
YOY1.1292.125-0.996
5Y1.0461.812-0.766
10Y1.2051.786-0.581
1.3.2. Quick Ratio

Measures if Torrent Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.54 means the company can pay off ₹0.54 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 0.544. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.544. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.544TTM0.5440.000
TTM0.544YOY0.496+0.047
TTM0.5445Y0.559-0.015
5Y0.55910Y0.736-0.177
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5441.118-0.574
TTM0.5441.152-0.608
YOY0.4961.091-0.595
5Y0.5591.007-0.448
10Y0.7360.869-0.133

1.4. Solvency of Torrent Pharmaceuticals Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Torrent Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Torrent Pharmaceuticals Limited to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.55 means that Torrent Pharmaceuticals Limited assets are financed with 54.6% credit (debt) and the remaining percentage (100% - 54.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 0.546. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.546. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.546TTM0.5460.000
TTM0.546YOY0.585-0.040
TTM0.5465Y0.626-0.080
5Y0.62610Y0.613+0.012
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5460.381+0.165
TTM0.5460.379+0.167
YOY0.5850.417+0.168
5Y0.6260.398+0.228
10Y0.6130.399+0.214
1.4.2. Debt to Equity Ratio

Measures if Torrent Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 120.1% means that company has ₹1.20 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 1.201. The company is able to pay all its debts with equity. +1
  • The TTM is 1.201. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.201TTM1.2010.000
TTM1.201YOY1.411-0.211
TTM1.2015Y1.719-0.518
5Y1.71910Y1.631+0.088
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2010.586+0.615
TTM1.2010.598+0.603
YOY1.4110.598+0.813
5Y1.7190.671+1.048
10Y1.6310.664+0.967

2. Market Valuation of Torrent Pharmaceuticals Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Torrent Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare Torrent Pharmaceuticals Limited to the Pharmaceuticals industry mean.
  • A PE ratio of 142.80 means the investor is paying ₹142.80 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Torrent Pharmaceuticals Limited:

  • The EOD is 67.826. Neutral. Compare to industry.
  • The MRQ is 142.800. Seems overpriced? -1
  • The TTM is 142.800. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD67.826MRQ142.800-74.974
MRQ142.800TTM142.8000.000
TTM142.800YOY75.717+67.083
TTM142.8005Y70.615+72.186
5Y70.61510Y53.845+16.769
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD67.82640.785+27.041
MRQ142.80051.661+91.139
TTM142.80051.419+91.381
YOY75.71764.495+11.222
5Y70.61556.903+13.712
10Y53.84561.712-7.867
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Torrent Pharmaceuticals Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Torrent Pharmaceuticals Limited:

  • The MRQ is 230.022. Seems overpriced? -1
  • The TTM is 230.022. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ230.022TTM230.0220.000
TTM230.022YOY123.955+106.067
TTM230.0225Y104.483+125.539
5Y104.48310Y104.4830.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ230.0220.015+230.007
TTM230.0220.036+229.986
YOY123.9550.327+123.628
5Y104.4830.144+104.339
10Y104.4830.144+104.339

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Torrent Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 18.64 means the investor is paying ₹18.64 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Torrent Pharmaceuticals Limited:

  • The EOD is 8.855. Seems overpriced? -1
  • The MRQ is 18.643. Seems overpriced? -1
  • The TTM is 18.643. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD8.855MRQ18.643-9.788
MRQ18.643TTM18.6430.000
TTM18.643YOY16.239+2.404
TTM18.6435Y10.579+8.065
5Y10.57910Y8.287+2.291
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD8.8552.248+6.607
MRQ18.6432.690+15.953
TTM18.6433.050+15.593
YOY16.2393.185+13.054
5Y10.5792.899+7.680
10Y8.2872.711+5.576
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Torrent Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.4213.4210%-112.552+3390%-16.235+575%29.315-88%
Book Value Growth--1.0201.0200%1.210-16%1.067-4%1.097-7%
Book Value Per Share--175.891175.8910%172.470+2%237.141-26%206.110-15%
Book Value Per Share Growth--1.0201.0200%0.605+69%0.946+8%0.946+8%
Current Ratio--1.1991.1990%1.129+6%1.046+15%1.205-1%
Debt To Asset Ratio--0.5460.5460%0.585-7%0.626-13%0.613-11%
Debt To Equity Ratio--1.2011.2010%1.411-15%1.719-30%1.631-26%
Dividend Per Share--20.00020.0000%10.000+100%21.281-6%19.740+1%
Dividend Per Share Growth--2.0002.0000%0.236+749%1.405+42%1.405+42%
Eps--22.96322.9630%36.989-38%37.272-38%34.504-33%
Eps Growth--0.6210.6210%0.611+2%0.990-37%0.990-37%
Free Cash Flow Per Share--47.28747.2870%49.521-5%45.637+4%43.172+10%
Free Cash Flow Per Share Growth--0.9550.9550%0.851+12%2.780-66%2.780-66%
Free Cash Flow To Equity Per Share---5.337-5.3370%0.745-817%31.903-117%29.828-118%
Free Cash Flow To Equity Per Share Growth---7.165-7.1650%2.022-454%0.871-923%0.871-923%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--796.737--------
Intrinsic Value_10Y_min--672.305--------
Intrinsic Value_1Y_max--54.427--------
Intrinsic Value_1Y_min--52.887--------
Intrinsic Value_3Y_max--182.899--------
Intrinsic Value_3Y_min--172.389--------
Intrinsic Value_5Y_max--334.720--------
Intrinsic Value_5Y_min--305.755--------
Net Profit Margin--0.0910.0910%0.156-42%0.110-17%0.138-34%
Operating Margin----0%-0%0.157-100%0.151-100%
Operating Ratio--1.0801.0800%1.036+4%1.0820%0.969+11%
Pb Ratio8.855-111%18.64318.6430%16.239+15%10.579+76%8.287+125%
Pe Ratio67.826-111%142.800142.8000%75.717+89%70.615+102%53.845+165%
Peg Ratio--230.022230.0220%123.955+86%104.483+120%104.483+120%
Price Per Share1557.500-111%3279.1503279.1500%2800.700+17%2222.940+48%1983.407+65%
Price To Total Gains Ratio66.500-111%140.010140.0100%-27.310+120%53.674+161%45.543+207%
Profit Growth--0.6210.6210%1.222-49%1.112-44%1.017-39%
Quick Ratio--0.5440.5440%0.496+10%0.559-3%0.736-26%
Return On Assets--0.0590.0590%0.089-33%0.060-1%0.084-29%
Return On Equity--0.1310.1310%0.214-39%0.159-18%0.215-39%
Revenue Growth--1.0631.0630%1.008+5%1.082-2%1.048+1%
Total Gains Per Share--23.42123.4210%-102.552+538%5.046+364%49.055-52%
Total Gains Per Share Growth--2.2282.2280%-2.123+195%0.595+275%0.595+275%
Usd Book Value--732212850.000732212850.0000%717971910.000+2%638613048.000+15%593986504.286+23%
Usd Book Value Change Per Share--0.0420.0420%-1.384+3390%-0.200+575%0.361-88%
Usd Book Value Per Share--2.1632.1630%2.121+2%2.917-26%2.535-15%
Usd Dividend Per Share--0.2460.2460%0.123+100%0.262-6%0.243+1%
Usd Eps--0.2820.2820%0.455-38%0.458-38%0.424-33%
Usd Free Cash Flow--196851660.000196851660.0000%206148000.000-5%135290406.000+46%96636004.286+104%
Usd Free Cash Flow Per Share--0.5820.5820%0.609-5%0.561+4%0.531+10%
Usd Free Cash Flow To Equity Per Share---0.066-0.0660%0.009-817%0.392-117%0.367-118%
Usd Price Per Share19.157-111%40.33440.3340%34.449+17%27.342+48%24.396+65%
Usd Profit--95593140.00095593140.0000%153981240.000-38%102536982.000-7%120100011.429-20%
Usd Revenue--1046488920.0001046488920.0000%984594090.000+6%936640326.000+12%889442168.571+18%
Usd Total Gains Per Share--0.2880.2880%-1.261+538%0.062+364%0.603-52%
 EOD+3 -2MRQTTM+0 -0YOY+22 -195Y+18 -2410Y+15 -27

3.2. Fundamental Score

Let's check the fundamental score of Torrent Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1567.826
Price to Book Ratio (EOD)Between0-18.855
Net Profit Margin (MRQ)Greater than00.091
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.544
Current Ratio (MRQ)Greater than11.199
Debt to Asset Ratio (MRQ)Less than10.546
Debt to Equity Ratio (MRQ)Less than11.201
Return on Equity (MRQ)Greater than0.150.131
Return on Assets (MRQ)Greater than0.050.059
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Torrent Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,575.550
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets130,998,400
Total Liabilities71,468,900
Total Stockholder Equity59,529,500
 As reported
Total Liabilities 71,468,900
Total Stockholder Equity+ 59,529,500
Total Assets = 130,998,400

Assets

Total Assets130,998,400
Total Current Assets52,946,500
Long-term Assets52,946,500
Total Current Assets
Cash And Cash Equivalents 3,755,900
Short-term Investments 1,845,500
Net Receivables 16,324,800
Inventory 25,189,200
Other Current Assets 2,196,900
Total Current Assets  (as reported)52,946,500
Total Current Assets  (calculated)49,312,300
+/- 3,634,200
Long-term Assets
Property Plant Equipment 32,469,300
Goodwill 2,594,800
Intangible Assets 35,460,600
Other Assets 5,182,500
Long-term Assets  (as reported)79,348,500
Long-term Assets  (calculated)75,707,200
+/- 3,641,300

Liabilities & Shareholders' Equity

Total Current Liabilities44,150,900
Long-term Liabilities27,318,000
Total Stockholder Equity59,529,500
Total Current Liabilities
Short-term Debt 9,230,400
Short Long Term Debt 18,948,800
Accounts payable 16,744,400
Other Current Liabilities 990,000
Total Current Liabilities  (as reported)44,150,900
Total Current Liabilities  (calculated)45,913,600
+/- 1,762,700
Long-term Liabilities
Long term Debt Total 21,600,400
Capital Lease Obligations 515,500
Long-term Liabilities Other 40,000
Long-term Liabilities  (as reported)27,318,000
Long-term Liabilities  (calculated)22,155,900
+/- 5,162,100
Total Stockholder Equity
Common Stock846,200
Retained Earnings 59,223,500
Capital Surplus 43,400
Other Stockholders Equity -583,600
Total Stockholder Equity (as reported)59,529,500
Total Stockholder Equity (calculated)59,529,500
+/-0
Other
Capital Stock846,200
Cash And Equivalents228,100
Cash and Short Term Investments 5,829,500
Common Stock Shares Outstanding 338,445
Liabilities and Stockholders Equity 130,998,400
Net Debt 36,197,000
Net Invested Capital 99,710,500
Net Working Capital 7,499,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
90,578,800
97,020,900
142,432,200
141,209,200
140,377,900
140,746,500
130,998,400
130,998,400140,746,500140,377,900141,209,200142,432,20097,020,90090,578,800
   > Total Current Assets 
46,882,100
48,793,800
52,623,200
50,375,300
50,071,100
55,232,200
52,946,500
52,946,50055,232,20050,071,10050,375,30052,623,20048,793,80046,882,100
       Cash And Cash Equivalents 
3,691,500
6,153,900
6,289,300
385,500
2,557,600
5,576,300
3,755,900
3,755,9005,576,3002,557,600385,5006,289,3006,153,9003,691,500
       Short-term Investments 
0
14,147,000
11,183,900
5,786,300
5,000
1,654,500
1,845,500
1,845,5001,654,5005,0005,786,30011,183,90014,147,0000
       Net Receivables 
14,450,900
9,508,900
12,534,500
14,357,100
16,493,400
15,233,700
16,324,800
16,324,80015,233,70016,493,40014,357,10012,534,5009,508,90014,450,900
       Inventory 
14,270,700
16,329,000
20,515,900
20,190,700
22,403,600
27,341,700
25,189,200
25,189,20027,341,70022,403,60020,190,70020,515,90016,329,00014,270,700
       Other Current Assets 
522,400
2,715,300
1,235,500
300,400
560,700
1,006,100
2,196,900
2,196,9001,006,100560,700300,4001,235,5002,715,300522,400
   > Long-term Assets 
0
47,415,600
89,809,000
90,833,900
90,288,200
85,530,000
79,348,500
79,348,50085,530,00090,288,20090,833,90089,809,00047,415,6000
       Property Plant Equipment 
20,167,300
23,343,100
28,400,100
32,799,900
35,299,200
36,287,500
32,469,300
32,469,30036,287,50035,299,20032,799,90028,400,10023,343,10020,167,300
       Goodwill 
1,248,800
1,595,000
3,985,200
3,347,900
3,420,900
3,412,300
2,594,800
2,594,8003,412,3003,420,9003,347,9003,985,2001,595,0001,248,800
       Intangible Assets 
17,590,500
17,141,200
52,630,900
47,500,500
43,730,400
39,840,300
35,460,600
35,460,60039,840,30043,730,40047,500,50052,630,90017,141,20017,590,500
       Long-term Assets Other 
0
0
0
0
0
240,000
260,000
260,000240,00000000
> Total Liabilities 
55,637,800
53,519,600
96,210,300
93,965,700
92,145,700
82,374,800
71,468,900
71,468,90082,374,80092,145,70093,965,70096,210,30053,519,60055,637,800
   > Total Current Liabilities 
32,854,800
27,382,600
52,021,700
51,653,200
54,822,100
48,916,200
44,150,900
44,150,90048,916,20054,822,10051,653,20052,021,70027,382,60032,854,800
       Short-term Debt 
33,200
0
16,256,000
9,341,100
10,908,500
7,044,000
9,230,400
9,230,4007,044,00010,908,5009,341,10016,256,000033,200
       Short Long Term Debt 
0
2,693,000
23,508,600
21,251,800
25,091,300
7,040,000
18,948,800
18,948,8007,040,00025,091,30021,251,80023,508,6002,693,0000
       Accounts payable 
0
22,978,700
20,482,400
20,967,400
20,768,600
20,670,000
16,744,400
16,744,40020,670,00020,768,60020,967,40020,482,40022,978,7000
       Other Current Liabilities 
0
300
7,000
16,900
0
1,280,000
990,000
990,0001,280,000016,9007,0003000
   > Long-term Liabilities 
0
26,132,100
44,183,400
42,312,500
37,323,600
33,460,000
27,318,000
27,318,00033,460,00037,323,60042,312,50044,183,40026,132,1000
       Long term Debt Total 
18,500,800
22,408,300
41,114,600
39,129,200
33,038,500
29,632,700
21,600,400
21,600,40029,632,70033,038,50039,129,20041,114,60022,408,30018,500,800
> Total Stockholder Equity
34,941,000
43,501,300
46,221,900
47,243,500
48,232,200
58,371,700
59,529,500
59,529,50058,371,70048,232,20047,243,50046,221,90043,501,30034,941,000
   Common Stock
846,200
846,200
846,200
846,200
846,200
846,200
846,200
846,200846,200846,200846,200846,200846,200846,200
   Retained Earnings 
34,227,600
41,447,600
45,594,200
46,220,300
48,987,000
58,121,400
59,223,500
59,223,50058,121,40048,987,00046,220,30045,594,20041,447,60034,227,600
   Capital Surplus 
43,400
43,400
43,400
43,400
43,400
43,400
43,400
43,40043,40043,40043,40043,40043,40043,400
   Treasury Stock0000000
   Other Stockholders Equity 
-176,200
1,164,100
-261,900
133,600
-1,644,400
-639,300
-583,600
-583,600-639,300-1,644,400133,600-261,9001,164,100-176,200



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue85,080,400
Cost of Revenue-25,374,700
Gross Profit59,705,70059,705,700
 
Operating Income (+$)
Gross Profit59,705,700
Operating Expense-66,494,600
Operating Income12,844,100-6,788,900
 
Operating Expense (+$)
Research Development386,500
Selling General Administrative30,606,100
Selling And Marketing Expenses-
Operating Expense66,494,60030,992,600
 
Net Interest Income (+$)
Interest Income661,000
Interest Expense-2,529,300
Net Interest Income-2,479,100-1,868,300
 
Pretax Income (+$)
Operating Income12,844,100
Net Interest Income-2,479,100
Other Non-Operating Income Expenses-
Income Before Tax (EBT)12,259,10012,844,100
EBIT - interestExpense = -2,529,300
7,771,800
10,301,100
Interest Expense2,529,300
Earnings Before Interest and Taxes (ebit)-14,788,400
Earnings Before Interest and Taxes (ebitda)21,407,700
 
After tax Income (+$)
Income Before Tax12,259,100
Tax Provision-4,487,300
Net Income From Continuing Ops7,771,8007,771,800
Net Income7,771,800
Net Income Applicable To Common Shares7,771,800
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,479,100
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
IPAXU.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IPAXU.NASDAQ.

IPAXU.NASDAQ Daily Candlestick Chart
CLT.CC
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CLT.CC.

CLT.CC Daily Candlestick Chart
CLB.CC
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CLB.CC.

CLB.CC Daily Candlestick Chart
CKB.CC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CKB.CC.

CKB.CC Daily Candlestick Chart
TR.V
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of TR.V.

TR.V Daily Candlestick Chart
NIFLN0000.CM
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NIFLN0000.CM.

NIFLN0000.CM Daily Candlestick Chart
AUTON0000.CM
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of AUTON0000.CM.

AUTON0000.CM Daily Candlestick Chart
VONEN0000.CM
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VONEN0000.CM.

VONEN0000.CM Daily Candlestick Chart
MELE.BR
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MELE.BR.

MELE.BR Daily Candlestick Chart
REN.JSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of REN.JSE.

REN.JSE Daily Candlestick Chart
CEU.PSE
2 hours ago

I found you a Golden Cross on the daily chart of CEU.PSE.

CEU.PSE Daily Candlestick Chart
HKY.OL
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of HKY.OL.

HKY.OL Daily Candlestick Chart
SLF-PK.TO
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SLF-PK.TO.

SLF-PK.TO Daily Candlestick Chart
DECCANCE.NSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECCANCE.NSE.

DECCANCE.NSE Daily Candlestick Chart
DECIPHER.BSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECIPHER.BSE.

DECIPHER.BSE Daily Candlestick Chart
DECCANCE.BSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DECCANCE.BSE.

DECCANCE.BSE Daily Candlestick Chart
CTE.NSE
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CTE.NSE.

CTE.NSE Daily Candlestick Chart
CRANEX.BSE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CRANEX.BSE.

CRANEX.BSE Daily Candlestick Chart
CPL.BSE
2 hours ago

I found you a Golden Cross on the daily chart of CPL.BSE.

CPL.BSE Daily Candlestick Chart
CONCOR.NSE
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CONCOR.NSE.

CONCOR.NSE Daily Candlestick Chart
COMSYN.BSE
2 hours ago

I found you a Death Cross on the daily chart of COMSYN.BSE.

COMSYN.BSE Daily Candlestick Chart
COMFINTE.BSE
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of COMFINTE.BSE.

COMFINTE.BSE Daily Candlestick Chart
COFFEEDAY.NSE
2 hours ago

I found you a Death Cross on the daily chart of COFFEEDAY.NSE.

COFFEEDAY.NSE Daily Candlestick Chart